Literature DB >> 12444601

Induction of radioprotective peroxiredoxin-I by ionizing irradiation.

Wen-Cheng Chen1, William H McBride, Keisuke S Iwamoto, Chad L Barber, Chun-Chieh Wang, Young-Taek Oh, Yu-Pei Liao, Ji-Hong Hong, Jean de Vellis, Hungyi Shau.   

Abstract

Results of this study indicate a radioprotective effect of peroxiredoxin-I. Peroxiredoxin-I is an antioxidant that scavenges hydroperoxides, whereas reactive oxygen species are the main mediators of ionizing radiation toxicity. We hypothesized that peroxiredoxin-I might be induced by cellular exposure to radiation and act to protect them against its cytotoxic effects. Western blot and Northern blot analyses were used to assess peroxiredoxin-I protein and mRNA expression. Rat C6 glioma cells were engineered to overexpress sense or antisense human peroxiredoxin-I using retroviral vectors. Clonogenic cell survival was used to assess radiosensitivities of the engineered cells. Ionizing radiation induced peroxiredoxin-I protein and mRNA expression in human HT29 colon cancer and rat C6 glioma cells in a dose- and time-dependent manner over a 24 hr period. To determine the effect of peroxiredoxin-I on radiation responses, C6 glioma cells were engineered to overexpress sense or antisense human peroxiredoxin-I. In clonogenic assays, cells overexpressing peroxiredoxin-I were more radioresistant. Cells transduced with antisense peroxiredoxin-I were marginally more sensitive to radiation toxicity. Irradiation can induce peroxiredoxin-I expression, and the increased peroxiredoxin-I may protect cells from further radiation damage. These results suggest that protection by peroxiredoxin-I may play an important role in the survival of glioma and colon cancer cells in patients undergoing radiation therapy. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12444601     DOI: 10.1002/jnr.10435

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  15 in total

1.  Investigation of molecular factors associated with malignant transformation of oligodendroglioma by proteomic study of a single case of rapid tumor progression.

Authors:  Chul-Kee Park; Jin Hyun Kim; Min Jeong Moon; Ji Hye Jung; Su-Young Lim; Sung-Hye Park; Jong-Hoon Kim; Dong Gyu Kim; Hee-Won Jung; Byung-Kyu Cho; Sun Ha Paek
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-26       Impact factor: 4.553

2.  HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation.

Authors:  R B Parmigiani; W S Xu; G Venta-Perez; H Erdjument-Bromage; M Yaneva; P Tempst; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-07       Impact factor: 11.205

3.  Sp1 inhibition-mediated upregulation of VEGF 165 b induced by rh-endostatin enhances antiangiogenic and anticancer effect of rh-endostatin in A549.

Authors:  Zhen-yu Li; Fang Zhu; Jian-li Hu; Gang Peng; Jing Chen; Sheng Zhang; Xu Chen; Rui-guang Zhang; Ling-juan Chen; Pian Liu; Ming Luo; Zhi-hua Sun; Jing-hua Ren; Li-li Huang; Gang Wu
Journal:  Tumour Biol       Date:  2011-03-26

4.  Glucose transporter protein 1 expression in mucoepidermoid carcinoma of salivary gland: correlation with grade of malignancy.

Authors:  Ana P D Demasi; Ana F Costa; Albina Altemani; Cristiane Furuse; Ney S Araújo; Vera C Araújo
Journal:  Int J Exp Pathol       Date:  2010-01-21       Impact factor: 1.925

Review 5.  The role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancer.

Authors:  Kenneth D Tew; Yefim Manevich; Christina Grek; Ying Xiong; Joachim Uys; Danyelle M Townsend
Journal:  Free Radic Biol Med       Date:  2011-04-22       Impact factor: 7.376

6.  Peroxiredoxin I expression in epithelial cells of buccal mucosa from patients exposed to panoramic X-rays: influence of the age.

Authors:  Milena B Silva; Ana P D Demasi; Elizabeth F Martinez; Maristane L Goudinho; Joarlene M Soares; José L C Junqueira; Ney S Araujo
Journal:  Clin Oral Investig       Date:  2017-10-23       Impact factor: 3.573

7.  Silencing Prx1 and/or Prx5 sensitizes human esophageal cancer cells to ionizing radiation and increases apoptosis via intracellular ROS accumulation.

Authors:  Mai-cang Gao; Xiao-di Jia; Qi-fei Wu; Yan Cheng; Fen-rong Chen; Jun Zhang
Journal:  Acta Pharmacol Sin       Date:  2011-04       Impact factor: 6.150

8.  Specific expression profile and prognostic significance of peroxiredoxins in grade II-IV astrocytic brain tumors.

Authors:  Sally Järvelä; Immo Rantala; Alejandra Rodriguez; Heini Kallio; Seppo Parkkila; Vuokko L Kinnula; Ylermi Soini; Hannu Haapasalo
Journal:  BMC Cancer       Date:  2010-03-22       Impact factor: 4.430

9.  Cloning and expression of mouse peroxiredoxin I in IEC-6 Cells.

Authors:  Bo Zhang; Yong-Ping Su; Tao Wang; Feng-Chao Wang; Guo-Ping Ai; Hui Xu; Jun-Ping Wang; Yue-Sheng Huang; Jian-Xin Jiang
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

10.  Discovery of biomarkers for osteosarcoma by proteomics approaches.

Authors:  Yoshiyuki Suehara; Daisuke Kubota; Kazutaka Kikuta; Kazuo Kaneko; Akira Kawai; Tadashi Kondo
Journal:  Sarcoma       Date:  2012-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.